P06.05 Myoinositol as a predictive baseline biomarker for overall survival of patients with recurrent glioblastoma treated with Bevacizumab: A 1H-magnetic resonance spectroscopy study.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.